199 related articles for article (PubMed ID: 22491045)
1. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
Benson AB; Arnoletti JP; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Dilawari RA; Engstrom PF; Enzinger PC; Fakih MG; Fleshman JW; Fuchs CS; Grem JL; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett C; Freedman-Cass DA;
J Natl Compr Canc Netw; 2012 Apr; 10(4):449-54. PubMed ID: 22491045
[TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography-computed tomography in the management of anal cancer.
Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
[TBL] [Abstract][Full Text] [Related]
3. Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma.
Horvat N; Jayaprakasam VS; Crane CH; Zheng J; Gangai N; Romesser PB; Golia Pernicka JS; Capanu M; Gollub MJ
Abdom Radiol (NY); 2024 May; 49(5):1351-1362. PubMed ID: 38456896
[TBL] [Abstract][Full Text] [Related]
4. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Hecht JR; Hoffe S; Hubbard J; Hunt S; Hussan H; Jeck W; Johung KL; Joseph N; Kirilcuk N; Krishnamurthi S; Maratt J; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Williams G; Algieri F; Gurski L; Stehman K
J Natl Compr Canc Netw; 2023 Jun; 21(6):653-677. PubMed ID: 37308125
[TBL] [Abstract][Full Text] [Related]
5. Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
Saboo SS; Zukotynski K; Shinagare AB; Krajewski KM; Ramaiya N
Abdom Imaging; 2013 Aug; 38(4):728-35. PubMed ID: 23011550
[TBL] [Abstract][Full Text] [Related]
6. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Jul; 16(7):852-871. PubMed ID: 30006428
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
[TBL] [Abstract][Full Text] [Related]
9. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Jones M; Hruby G; Solomon M; Rutherford N; Martin J
Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
[TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
Nguyen BD; Ram PC; Roarke MC
Clin Nucl Med; 2007 Mar; 32(3):234-6. PubMed ID: 17314608
[No Abstract] [Full Text] [Related]
11. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.
Trautmann TG; Zuger JH
Mol Imaging Biol; 2005; 7(4):309-13. PubMed ID: 16028002
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
14. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
Milano MT; Jani AB; Farrey KJ; Rash C; Heimann R; Chmura SJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):354-61. PubMed ID: 16168830
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET/CT: new horizons in anal cancer.
Grigsby PW
Gastroenterol Clin Biol; 2009 May; 33(5):456-8. PubMed ID: 19394179
[TBL] [Abstract][Full Text] [Related]
16. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
Golia Pernicka JS; Rauch GM; Gangai N; Bates DDB; Ernst R; Hope TA; Horvat N; Sheedy SP; Gollub MJ
Abdom Radiol (NY); 2023 Sep; 48(9):3022-3032. PubMed ID: 36932225
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of FDG-PET in the management of anal cancer.
Nguyen BT; Joon DL; Khoo V; Quong G; Chao M; Wada M; Joon ML; See A; Feigen M; Rykers K; Kai C; Zupan E; Scott A
Radiother Oncol; 2008 Jun; 87(3):376-82. PubMed ID: 18453023
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT in the management of colorectal and anal cancers.
Agarwal A; Marcus C; Xiao J; Nene P; Kachnic LA; Subramaniam RM
AJR Am J Roentgenol; 2014 Nov; 203(5):1109-19. PubMed ID: 25341152
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
Schmults CD; Blitzblau R; Aasi SZ; Alam M; Andersen JS; Baumann BC; Bordeaux J; Chen PL; Chin R; Contreras CM; DiMaio D; Donigan JM; Farma JM; Ghosh K; Grekin RC; Harms K; Ho AL; Holder A; Lukens JN; Medina T; Nehal KS; Nghiem P; Park S; Patel T; Puzanov I; Scott J; Sekulic A; Shaha AR; Srivastava D; Stebbins W; Thomas V; Xu YG; McCullough B; Dwyer MA; Nguyen MQ
J Natl Compr Canc Netw; 2021 Dec; 19(12):1382-1394. PubMed ID: 34902824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
